MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
Triple Helix: Global Regional Innovation Clusters (RICs)
*Triple Helix Cluster & Developments: North America
*Triple Helix Cluster & Developments: U.S.
*Triple Helix Cluster & Developments: Connecticut
Industry: Connecticut
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)*
Organization & Developments: SpringWorks Therapeutics
Parents
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)*
Children
*The company's lead product candidate is Nirogacestat, an oral small molecule gamma-secretase inhibitor, which is being developed as a monotherapy for the treatment of desmoid tumors.
2022: SpringWorks Therapeutics (SWTX) Investor Presentation - Slideshow_seekingalpha.com
2022: SpringWorks Therapeutics: Rating Buy Ahead Of Mid-Year Data Releases_seekingalpha.com
2023: SpringWorks Therapeutics: Surging On Ogsiveo Approval, Long-Term Outlook Remains Unclear_seekingalpha.com
2023: SpringWorks: Springing Forward On FDA Approval, Right Into Overpriced Territory_seekingalpha.com
2024: FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
2024: SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Good Position To Deliver On Growth Plans
2024: SpringWorks Therapeutics Merits A Speculative Buy
2024: SpringWorks Therapeutics Recent Developments Move This To Speculative Buy (Upgrade)
2024: SpringWorks Therapeutics: Rising On A Strong Post-Launch Quarter, Now Justified As A Buy
2024: SpringWorks Therapeutics' SWOT analysis: biotech stock shows promise amid challenges
2024: SpringWorks: With Catalyst On The Horizon And Growing Sales, 2025 Looks Great_seekingalpha.com
2024: Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks
2025: SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz_ seekingalpha.com
2025: SpringWorks: PDUFA Review Date Could Lead To Next Approved Pipeline Candidate
Jumps
Finance & Acquisitions: SpringWorks Therapeutics
Key People : SpringWorks Therapeutics